Brigham & Women’s Hospital
Department of Medicine
Division of Pharmacoepidemiology & Pharmacoeconomics
1620 Tremont Street, Suite 3030,
Boston, MA 02120
Phone: 617-278-0930 | Fax: 617-232-8602
Robert J. Glynn, Sc.D., Ph.D., is a Professor of Medicine (Biostatistics) at Harvard Medical School, where he divides his time between the Divisions of Preventive Medicine and Pharmacoepidemiology and Pharmacoeconomics. He also teaches at the Harvard School of Public Health where he is an Associate Professor of Biostatistics. For over 30 years, his work has focused on the design and analysis of studies of risk factors and treatments for common chronic diseases in older people. Dr. Glynn has designed, monitored, and analyzed data from large-scale randomized trials, prospective cohort studies and case-control studies. His methodological interests include methods for missing data, analysis of clustered data, competing risks, and approaches to identify and adjust for selection bias. He is currently principal investigator of studies on the epidemiology of venous thromboembolism, factors influencing drug choice in older people, and independent monitoring of the ongoing JUPITER Trial. Dr. Glynn has served on numerous data monitoring boards and is the author of over 300 peer-reviewed, original papers.
Selected Publications | Current PubMed Search Results
- Glynn RJ, Brookhart MA, Stedman M, Avorn J, Solomon DH. Design of cluster-randomized trials of quality-improvement interventions aimed at medical care providers. Med Care 2007; 45: s38-s43.
- Glynn RJ, Ridker PM, Goldhaber SZ, Buring JE. Effects of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial. Ann Intern Med 2007; 147: 525-533.
- Glynn RJ, Ridker PM, Goldhaber SZ, Zee RYL, Buring JE. Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women’s Health Study. Circulation 2007; 116: 1497-1503.
- Glynn RJ, Schneeweiss S, Wang PS, Levin R, Avorn J. Selective prescribing led to overestimation of the benefits of lipid lowering drugs. J Clin Epidemiol 2006; 59: 819-828.
- Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke and venous thromboembolism. Am J Epidemiol 2005; 162: 975-982.
- Glynn RJ, Knight EL, Levin R, Avorn J. Paradoxical relationships of drug treatment with mortality in older persons. Epidemiology 2001; 12:682-689.
- Glynn RJ, Beckett LA, Hebert LE, Morris MC, Scherr PA, Evans DA. Current and remote blood pressure and cognitive decline. JAMA 1999; 281:438-445.
- Glynn RJ, Field TS, Rosner B, Hebert PR, Taylor J, Hennekens CH. Evidence for a positive linear relation between blood pressure and mortality in elderly people. Lancet 1995; 345:825-829.
- Glynn RJ, Laird NM, Rubin DB. Multiple imputation in mixture models for nonignorable nonresponse with follow-ups. J Am Statist Assoc 1993; 88:984-993.
- Glynn RJ, Rosner B. Accounting for the correlation between fellow eyes in regression analysis. Arch Ophthalmol 1992; 110:381-387.
- Glynn RJ, Campion EW, Bouchard GR, Silbert JE. The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. Am J Epidemiol 1985; 121:78-90.